ABSTRACT… Introduction: Contrast induced nephropathy (CIN) is a disorder characterized by the onset of acute renal failure within 24 to 72 hours after the administration of iodinated contrast medium after coronary angiography. CIN is associated with prolonged hospitalization and adverse clinical outcomes. The objective of this study is to determine the frequency of contrast induced nephropathy in patients of coronary artery disease undergoing coronary angiography in local population. Setting: Department of Cardiology, Faisalabad Institute of Cardiology. Period: 16-04-2016 to 15-10-2016. Subjects and Methods: 200 patients of coronary artery disease booked for coronary angiogram. Study design was Cross-sectional. Baseline characteristic and history of risk factors of coronary artery disease were noted. Serum creatinine level was recorded at baseline and after 48 hours of angiography by sending blood sample to the hospital pathology department and were noted. Contrast induced nephropathy was assessed. Results: Mean age of the patients was 53.61±12.48 year. Patients with age between 30-50 years were 76(38%) and patients with age 51-70 years were 124 (62%). Out of 200 patients, 130 (65%) were males while remaining 70 (35%) were females. In the study population 14 (7%) developed contrast induced nephropathy (CIN). Mostly patients of 51-70 years of age group developed CIN. CIN was reported in 9(6.92%) male patients and 5(7.1%) female patients. Among diabetic 4 (3.57%) patient developed CIN. Among hypertensive patients 2 (2.77%) patient developed CIN. Similarly in patients presented with acute coronary syndrome 8 (7.61%) patient developed CIN. Conclusion: In conclusion, contrast induced nephropathy in patients with coronary artery disease undergoing coronary angiogram was found in 7%. CIN is a relative common finding following coronary angiography in patients especially in elderly and male patients. More incidences of CIN were noted in patients presented with acute coronary syndrome and in diabetic patients. key words:Contrast induced nephropathy, Coronary angiography.
Introduction: Contrast induced nephropathy (CIN) is a disorder characterizedby the onset of acute renal failure within 24 to 72 hours after the administration of iodinatedcontrast medium after coronary angiography. CIN is associated with prolonged hospitalizationand adverse clinical outcomes. The objective of this study is to determine the frequency ofcontrast induced nephropathy in patients of coronary artery disease undergoing coronaryangiography in local population. Setting: Department of Cardiology, Faisalabad Instituteof Cardiology. Period: 16-04-2016 to 15-10-2016. Subjects and Methods: 200 patients ofcoronary artery disease booked for coronary angiogram. Study design was Cross-sectional.Baseline characteristic and history of risk factors of coronary artery disease were noted. Serumcreatinine level was recorded at baseline and after 48 hours of angiography by sending bloodsample to the hospital pathology department and were noted. Contrast induced nephropathywas assessed. Results: Mean age of the patients was 53.61±12.48 year. Patients with agebetween 30-50 years were 76(38%) and patients with age 51-70 years were 124 (62%). Outof 200 patients, 130 (65%) were males while remaining 70 (35%) were females. In the studypopulation 14 (7%) developed contrast induced nephropathy (CIN). Mostly patients of 51-70years of age group developed CIN. CIN was reported in 9(6.92%) male patients and 5(7.1%)female patients. Among diabetic 4 (3.57%) patient developed CIN. Among hypertensive patients2 (2.77%) patient developed CIN. Similarly in patients presented with acute coronary syndrome8 (7.61%) patient developed CIN. Conclusion: In conclusion, contrast induced nephropathy inpatients with coronary artery disease undergoing coronary angiogram was found in 7%. CIN isa relative common finding following coronary angiography in patients especially in elderly andmale patients. More incidences of CIN were noted in patients presented with acute coronarysyndrome and in diabetic patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.